Policosanol Blood Pressure Meta-Analysis Evidence Table

Structured evidence table for Policosanol Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Policosanol Blood Pressure Meta-AnalysisIt is concluded that oral administration of policosanol 20 mg/day for twelve weeks significantly lowered SBP and DBP in Cuban patients with grade I hypertension, and improved lipid profile variables, being safe and well tolerated.2Revueltas Aguero M (2025)Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
Policosanol Blood Pressure Meta-AnalysisThis study aimed to report the effects of policosanol (20 mg/day) on blood pressure values in Cuban patients with grade I hypertension.2Revueltas Aguero M (2025)Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
Policosanol Blood Pressure Meta-AnalysisA double-blind multicenter trial randomized 400 eligible patients divided into two strata of patients with either prehypertension or grade I hypertension (200 patients each) treated with either placebo or policosanol 20 mg/day (100 patients/group/stratum) for 12 weeks.2Revueltas Aguero M (2025)Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
Policosanol Blood Pressure Meta-Analysis1 2 Hypertension is the most frequent modifiable cardiovascular risk factor, with more than 1 billion individuals living with high blood pressure worldwide [].2Revueltas Moura (2025)Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
Policosanol Blood Pressure Meta-Analysis3 Evidence has proven the impact of lowering blood pressure for improving cardiovascular outcomes and all‐cause mortality [], making clear the relevance of promoting knowledge, prevention, and treatment of high blood pressure levels.2Revueltas Moura (2025)Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
Policosanol Blood Pressure Meta-AnalysisAll guidelines agree that at the prehypertension stage, doctors may choose to initially manage hypertension with lifestyle changes only but may add medication based on the patient's overall cardiovascular risk.2Revueltas Moura (2025)Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
Policosanol Blood Pressure Meta-AnalysisHypertension has been widely recognized as the leading cause of cardiovascular disease and the main contributor of global mortality [].2Revueltas Moura (2025)Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
topicPolicosanol Blood Pressure Meta-Analysis
claimIt is concluded that oral administration of policosanol 20 mg/day for twelve weeks significantly lowered SBP and DBP in Cuban patients with grade I hypertension, and improved lipid profile variables, being safe and well tolerated.
evidence level2
citationRevueltas Aguero M (2025)
sourcePolicosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
topicPolicosanol Blood Pressure Meta-Analysis
claimThis study aimed to report the effects of policosanol (20 mg/day) on blood pressure values in Cuban patients with grade I hypertension.
evidence level2
citationRevueltas Aguero M (2025)
sourcePolicosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
topicPolicosanol Blood Pressure Meta-Analysis
claimA double-blind multicenter trial randomized 400 eligible patients divided into two strata of patients with either prehypertension or grade I hypertension (200 patients each) treated with either placebo or policosanol 20 mg/day (100 patients/group/stratum) for 12 weeks.
evidence level2
citationRevueltas Aguero M (2025)
sourcePolicosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
topicPolicosanol Blood Pressure Meta-Analysis
claim1 2 Hypertension is the most frequent modifiable cardiovascular risk factor, with more than 1 billion individuals living with high blood pressure worldwide [].
evidence level2
citationRevueltas Moura (2025)
sourceEfficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
topicPolicosanol Blood Pressure Meta-Analysis
claim3 Evidence has proven the impact of lowering blood pressure for improving cardiovascular outcomes and all‐cause mortality [], making clear the relevance of promoting knowledge, prevention, and treatment of high blood pressure levels.
evidence level2
citationRevueltas Moura (2025)
sourceEfficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
topicPolicosanol Blood Pressure Meta-Analysis
claimAll guidelines agree that at the prehypertension stage, doctors may choose to initially manage hypertension with lifestyle changes only but may add medication based on the patient's overall cardiovascular risk.
evidence level2
citationRevueltas Moura (2025)
sourceEfficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study
topicPolicosanol Blood Pressure Meta-Analysis
claimHypertension has been widely recognized as the leading cause of cardiovascular disease and the main contributor of global mortality [].
evidence level2
citationRevueltas Moura (2025)
sourceEfficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study

Source documents

  1. Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study.
  2. Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double‐Blind, Multicentre Study